Corient Private Wealth LLC Grows Stake in iShares Biotechnology ETF $IBB

Corient Private Wealth LLC boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 113.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 62,227 shares of the financial services provider’s stock after buying an additional 33,099 shares during the period. Corient Private Wealth LLC owned approximately 0.13% of iShares Biotechnology ETF worth $10,503,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Basepoint Wealth LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $26,000. Cary Street Partners Financial LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth $29,000. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the second quarter worth $25,000. Caitlin John LLC bought a new position in iShares Biotechnology ETF in the fourth quarter valued at $34,000. Finally, Cornerstone Planning Group LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $35,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.9%

IBB opened at $181.53 on Thursday. The stock has a 50-day moving average price of $171.07 and a 200-day moving average price of $170.83. iShares Biotechnology ETF has a 12-month low of $125.70 and a 12-month high of $183.04.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were paid a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.